{"name": "Agendia",
 "permalink": "agendia",
 "crunchbase_url": "http://www.crunchbase.com/company/agendia",
 "homepage_url": "http://www.agendia.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "Agendia",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2003,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "+31 20 462 1500",
 "description": "biotechnology company",
 "created_at": "Thu Sep 24 09:49:40 UTC 2009",
 "updated_at": "Mon Mar 25 04:15:38 UTC 2013",
 "overview": "\u003Cp\u003EAgendia\u00e2\u20ac\u2122s molecular diagnostic technology provides cancer patients and their physicians with a glimpse into their genome, answers to the most pressing questions and enables personalized treatment plans. \u003C/p\u003E\n\n\u003Cp\u003EMammaPrint\u00c2\u00ae, Agendia\u00e2\u20ac\u2122s main product for breast cancer, analyzes tumors based on a 70 gene signature and offers innovative, unbiased and clinically significant insight into tumor biology. It is the first FDA cleared breast cancer gene profiling assay of its kind and provides a highly accurate determination of metastasis risk (low or high) and distant recurrence within 10 years.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[100,
       60],
      "assets/images/resized/0006/0693/60693v1-max-150x150.png"],
     [[100,
       60],
      "assets/images/resized/0006/0693/60693v1-max-250x250.png"],
     [[100,
       60],
      "assets/images/resized/0006/0693/60693v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "David",
      "last_name": "Macdonald",
      "permalink": "david-macdonald",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Kurt",
      "last_name": "Schmidt",
      "permalink": "kurt-schmidt",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$122M",
 "funding_rounds":
  [{"round_code": "e",
    "source_url": "http://www.fiercebiotech.com/story/agendia-closes-23m-series-e-financing/2009-09-23?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
    "source_description": "Agendia closes $23M Series E financing",
    "raised_amount": 23000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 9,
    "funded_day": 23,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "ING Group",
         "permalink": "ing-group",
         "image":
          {"available_sizes":
            [[[130,
               39],
              "assets/images/resized/0004/9295/49295v1-max-150x150.png"],
             [[130,
               39],
              "assets/images/resized/0004/9295/49295v1-max-250x250.png"],
             [[130,
               39],
              "assets/images/resized/0004/9295/49295v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Van Herk Biotech",
         "permalink": "van-herk-biotech",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Gilde Healthcare Partners",
         "permalink": "gilde-healthcare-partners",
         "image":
          {"available_sizes":
            [[[150,
               44],
              "assets/images/resized/0005/3138/53138v2-max-150x150.png"],
             [[201,
               59],
              "assets/images/resized/0005/3138/53138v2-max-250x250.png"],
             [[201,
               59],
              "assets/images/resized/0005/3138/53138v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Global Life Science Ventures",
         "permalink": "global-life-science-ventures",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0005/9922/59922v1-max-150x150.jpg"],
             [[208,
               80],
              "assets/images/resized/0005/9922/59922v1-max-250x250.jpg"],
             [[208,
               80],
              "assets/images/resized/0005/9922/59922v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://www.agendia.com/pages/press_release/70.php?aid=47",
    "source_description": "Agendia BV raises $34M and Receives Second FDA Clearance",
    "raised_amount": 34000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 8,
    "funded_day": 28,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Van Herk Biotech",
         "permalink": "van-herk-biotech",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Gilde Healthcare Partners",
         "permalink": "gilde-healthcare-partners",
         "image":
          {"available_sizes":
            [[[150,
               44],
              "assets/images/resized/0005/3138/53138v2-max-150x150.png"],
             [[201,
               59],
              "assets/images/resized/0005/3138/53138v2-max-250x250.png"],
             [[201,
               59],
              "assets/images/resized/0005/3138/53138v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Global Life Science Ventures",
         "permalink": "global-life-science-ventures",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0005/9922/59922v1-max-150x150.jpg"],
             [[208,
               80],
              "assets/images/resized/0005/9922/59922v1-max-250x250.jpg"],
             [[208,
               80],
              "assets/images/resized/0005/9922/59922v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.bizjournals.com/sanfrancisco/prnewswire/press_releases/California/2012/05/31/NY15229",
    "source_description": "Agendia Raises $65 Million in a Private Round of Equity Financing",
    "raised_amount": 65000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 5,
    "funded_day": 31,
    "investments":
     [{"company":
        {"name": "Debiopharm Group",
         "permalink": "debiopharm",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0011/1746/111746v1-max-150x150.png"],
             [[250,
               29],
              "assets/images/resized/0011/1746/111746v1-max-250x250.png"],
             [[408,
               48],
              "assets/images/resized/0011/1746/111746v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ING Corporate Investments",
         "permalink": "ing-corporate-investments",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0027/2301/272301v2-max-150x150.png"],
             [[211,
               61],
              "assets/images/resized/0027/2301/272301v2-max-250x250.png"],
             [[211,
               61],
              "assets/images/resized/0027/2301/272301v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Breedinvest",
         "permalink": "breedinvest",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Gilde Healthcare Partners",
         "permalink": "gilde-healthcare-partners",
         "image":
          {"available_sizes":
            [[[150,
               44],
              "assets/images/resized/0005/3138/53138v2-max-150x150.png"],
             [[201,
               59],
              "assets/images/resized/0005/3138/53138v2-max-250x250.png"],
             [[201,
               59],
              "assets/images/resized/0005/3138/53138v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Van Herk Biotech",
         "permalink": "van-herk-biotech",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "Science Park 406",
    "address2": "",
    "zip_code": "1098 XH",
    "city": "Amsterdam",
    "state_code": null,
    "country_code": "NLD",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        131],
       "assets/images/resized/0006/0694/60694v1-max-150x150.jpg"],
      [[250,
        219],
       "assets/images/resized/0006/0694/60694v1-max-250x250.jpg"],
      [[450,
        395],
       "assets/images/resized/0006/0694/60694v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}